Yan Cai

Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Systematic Multiplatform Discovery of Methylation Markers Enables Non-Invasive Early Detection of Endometrial Cancer.

Systematic Multiplatform Discovery of Methylation Markers Enables Non-Invasive Early Detection of Endometrial Cancer.

Journal: Cancer science

Published: September 07, 2025

Combination of PARP Inhibitor and Antiangiogenic Therapy Following Disease Progression in Patients With Epithelial Ovarian Cancer Undergoing PARP Inhibitor Maintenance Therapy: A Real-World Study.

Combination of PARP Inhibitor and Antiangiogenic Therapy Following Disease Progression in Patients With Epithelial Ovarian Cancer Undergoing PARP Inhibitor Maintenance Therapy: A Real-World Study.

Journal: BJOG : an international journal of obstetrics and gynaecology

Published: November 28, 2024

The prognostic value of tumor-informed minimal residual disease detection using circulating tumor DNA in first-line treatment of ovarian cancer.

The prognostic value of tumor-informed minimal residual disease detection using circulating tumor DNA in first-line treatment of ovarian cancer.

Journal: Gynecologic oncology

Published: June 08, 2024

Elevated nonhomologous end-joining by AATF enables efficient DNA damage repair and therapeutic resistance in glioblastoma.

Elevated nonhomologous end-joining by AATF enables efficient DNA damage repair and therapeutic resistance in glioblastoma.

Journal: Nature communications

Published: May 15, 2024

FSD1 inhibits glioblastoma diffuse infiltration through restriction of HDAC6-mediated microtubule deacetylation.

FSD1 inhibits glioblastoma diffuse infiltration through restriction of HDAC6-mediated microtubule deacetylation.

Journal: Science China. Life sciences

Published: April 05, 2024

Phosphocreatine Promotes Epigenetic Reprogramming to Facilitate Glioblastoma Growth Through Stabilizing BRD2.

Phosphocreatine Promotes Epigenetic Reprogramming to Facilitate Glioblastoma Growth Through Stabilizing BRD2.

Journal: Cancer discovery

Published: November 13, 2023

Nuclear-cytoplasmic translocation of SQSTM1/p62 protein enhances ESCC cell migration and invasion by stabilizing EPLIN expression.

Nuclear-cytoplasmic translocation of SQSTM1/p62 protein enhances ESCC cell migration and invasion by stabilizing EPLIN expression.

Journal: Experimental cell research

Published: October 10, 2023

Tenascin-C as a potential biomarker and therapeutic target for esophageal squamous cell carcinoma.

Tenascin-C as a potential biomarker and therapeutic target for esophageal squamous cell carcinoma.

Journal: Translational oncology

Published: September 03, 2023

Disparities in treatment modalities and survival among older patients with high-grade serous ovarian cancer.

Disparities in treatment modalities and survival among older patients with high-grade serous ovarian cancer.

Journal: BMC women's health

Published: September 02, 2023

A real-world study of treatment patterns following disease progression in epithelial ovarian cancer patients undergoing poly-ADP-ribose polymerase inhibitor maintenance therapy.

A real-world study of treatment patterns following disease progression in epithelial ovarian cancer patients undergoing poly-ADP-ribose polymerase inhibitor maintenance therapy.

Journal: Journal of ovarian research

Published: August 14, 2023

Elevated expression of the RNA-binding protein IGF2BP1 enhances the mRNA stability of INHBA to promote the invasion and migration of esophageal squamous cancer cells.

Elevated expression of the RNA-binding protein IGF2BP1 enhances the mRNA stability of INHBA to promote the invasion and migration of esophageal squamous cancer cells.

Journal: Experimental hematology & oncology

Published: November 10, 2022

Development of novel DNAJB6-KIAA1522-p-mTOR three-protein prognostic prediction models for CRC.

Development of novel DNAJB6-KIAA1522-p-mTOR three-protein prognostic prediction models for CRC.

Journal: Translational oncology

Published: September 11, 2022

Showing 1-12 of 80

Last Updated: 09/26/2026